Prime Medicine (PRME) PT Lowered to $7 at Stifel
Tweet
Share
E-mailGet Alerts PRME Hot Sheet
Price: $3.09 -2.52%
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel analyst Dae Gon Ha lowered the price target on Prime Medicine (NASDAQ: PRME) to $7.00 (from $8.00) while maintaining a Hold rating.
You May Also Be Interested In
- Prime Drink Group Provides Bi-Weekly MCTO Status Report
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
